Expert Review of Vaccines

Papers
(The TQCC of Expert Review of Vaccines is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Impact of the Delta variant on vaccine efficacy and response strategies167
Restoring confidence in vaccines in the COVID-19 era152
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?133
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies126
COVID-19 vaccine: where are we now and where should we go?104
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination83
Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases76
How can a global pandemic affect vaccine hesitancy?74
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era73
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations64
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China61
ExploringKlebsiella pneumoniaecapsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia60
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis57
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?56
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China53
COVID-19 vaccines: concerns beyond protective efficacy and safety53
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy52
Nanovaccine: an emerging strategy51
Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy50
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies49
Global impact of delta plus variant and vaccination47
Social media strategies to affect vaccine acceptance: a systematic literature review46
COVID-19 vaccination in pregnant and lactating women: a systematic review45
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination45
COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa45
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-1944
Recent advances in human norovirus research and implications for candidate vaccines44
Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection44
Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication41
An overview ofin silicovaccine design against different pathogens and cancer41
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update41
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China40
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign36
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence32
Expert review on global real-world vaccine effectiveness against SARS-CoV-230
COVID-19 vaccine equity: a health systems and policy perspective30
COVID-19 and vaccination: myths vs science30
Vaccine hesitancy in health-care providers in Western countries: a narrative review29
Upper respiratory tract colonization withStreptococcus pneumoniaein adults29
COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis29
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials29
Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic28
Thermostable vaccines: an innovative concept in vaccine development27
Microneedle Systems for Vaccine Delivery: the story so far27
The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)27
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection26
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?26
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis25
Clinical development and approval of COVID-19 vaccines25
Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication24
Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis24
Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)23
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis23
Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges23
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome23
The potential impact of COVID-19 pandemic on the immunization performance in Indonesia23
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic22
Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape22
Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production21
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways21
Diabetes mellitus as a vaccine-effect modifier: a review21
The development of ghost vaccines trials21
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations21
COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy20
Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?20
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children19
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh19
Vaccination against SARS-CoV-2 and disease enhancement – knowns and unknowns19
Overcoming roadblocks in the development of vaccines for leishmaniasis19
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations18
Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach18
COVID-19 vaccine design and vaccination strategy for emerging variants18
Progress towards the development of a P. vivax vaccine18
Influenza vaccine: progress in a vaccine that elicits a broad immune response18
The epidemic of erythromycin-resistant Bordetella pertussis with limited genome variation associated with pertussis resurgence in China18
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years18
Vaccinomics: a future avenue for vaccine development against emerging pathogens17
Eradicating polio in Pakistan: a systematic review of programs and policies17
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy17
Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent?17
Immunoinformatics-guided designing and in silico analysis of epitope-based polyvalent vaccines against multiple strains of human coronavirus (HCoV)16
Seasonal influenza vaccine hesitancy profiles and determinants among Chinese children’s guardians and the elderly16
Use of lentiviral vectors in vaccination16
GMMA as a ‘plug and play’ technology to tackle infectious disease to improve global health: context and perspectives for the future16
An overview of rotavirus vaccination programs in developing countries16
Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis15
Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis15
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China15
Drivers of hesitancy towards recommended childhood vaccines in African settings: a scoping review of literature from Kenya, Malawi and Ethiopia15
Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review15
Correlates of malaria vaccine efficacy15
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?15
The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia15
Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization15
Recent advances in lipopolysaccharide-based glycoconjugate vaccines14
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis14
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease14
Recommendations to drive a value-based decision-making on vaccination14
Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization14
Varicella vaccination in Italy and Germany – different routes to success: a systematic review14
Multi-functional antibody profiling for malaria vaccine development and evaluation14
The challenges of a circumsporozoite protein-based malaria vaccine14
Evaluating the relationship between myocarditis and mRNA vaccination14
Immune interference (blunting) in the context of maternal immunization with Tdap-containing vaccines: is it a class effect?14
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy14
Vaccine development against methamphetamine drug addiction14
Why METH users are at high risk of fatality due to COVID-19 infection?13
Measles, mumps, rubella prevention: how can we do better?13
Challenges targeting cancer neoantigens in 2021: a systematic literature review13
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis13
COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines.12
Progress and new horizons toward a VAR2CSA-based placental malaria vaccine12
Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions12
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a revi12
Immunoinformatics driven construction of multi-epitope vaccine candidate against Ascaris lumbricoides using its entire immunogenic epitopes12
Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy12
Structural vaccinology of malaria transmission-blocking vaccines12
Monkeypox: a new face of outbreak12
Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study12
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review12
Vaccination strategies between compulsion and incentives. The Italian Green Pass experience12
Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes11
Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains11
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned11
Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention11
An instrument to measure psychosocial determinants of health care professionals’ vaccination behavior: Validation of the Pro-VC-Be questionnaire11
Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring11
Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review11
Combating the great mimicker: latest progress in the development ofBurkholderia pseudomalleivaccines11
Vaccine adherence: the rate of hesitancy toward childhood immunization in Kazakhstan11
The race for a COVID-19 vaccine: where are we up to?11
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh11
COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey11
Prevalence and management of measles susceptibility in healthcare workers in Italy: a systematic review and meta-analysis11
0.02535605430603